Skip to main content

A Study of Lebrikizumab (LY3650150) in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Previously Treated With Dupilumab

Completed · Phase 3 · NCT05369403

Conditions: Atopic Dermatitis

At a glance

Research payments reported, 2025
$445,777
U.S. investigators named
34
Sites paid
35
Planned or actual enrollment
86

About the trial

Sponsor
Eli Lilly and Company
Tested
Lebrikizumab (drug)
Dates
Started 2022-12-19; completion 2025-02-05
Results posted
Yes

The study will assess the safety and efficacy of lebrikizumab in adult and adolescent participants with moderate-to-severe atopic dermatitis (AD) previously treated with Dupilumab.

From ClinicalTrials.gov, last updated 2026-02-25. Full record, eligibility and contacts (opens in a new tab)

Industry funding

Eli Lilly and Company reported $445,777 in research payments for this study in 2025 (38 payments).

Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.

U.S. investigators named on this study

Clinicians the company named as principal investigators in its Open Payments reports.

Sites paid to run it

  • Dorisca Research Consulting LLC $30,705
  • Dawes Fretzin Clinical Research Group LLC $25,588
  • Dermassociates PC $24,296
  • DBA Miami Dermatology & Laser Research LLC $22,977
  • Southwest Skin Specialists LLC $20,564
  • Paul Getz MD Sc $18,869
  • Advanced Medical Research Inc $18,812
  • Sadick Research Group LLC $18,319
  • Revival Research Institute LLC $18,264
  • Allcutis Research LLC $16,986
  • $15,923
  • Academic Alliance in Dermatology $15,720
  • Dermatology Research Associates Inc $14,857
  • The Pennsylvania Centre for Dermatology LLC $14,288
  • Complete Dermatology $13,253
  • Dermatology Institute and Skin Care $12,794
  • Ziaderm Research LLC $12,774
  • Jerry Bagel MD LLC $12,194
  • University of Connecticut Health $11,763
  • Premier Clinical Research $11,376
  • Markowitz Medical PLLC $11,208
  • Elias Research Associates LLC $10,983
  • 113 Efficient Services $10,282
  • Skin Care Research LLC $10,258
  • Pharmaseek Financial Services $10,132
  • Dermatologic Surgical Specialists $9,376
  • Wallace Medical Group Inc $9,069
  • Total Vein and Skin LLC $5,807
  • Shondra L Smith MD $4,405
  • Medisearch LLC $3,926
  • Avance Clinical Trials Inc $2,874
  • Tory Sullivan MD PA $2,781
  • Clinical PArtners LLC $1,885
  • Avance Trials $1,147
  • Oakland Hills Dermatology PC $936
  • Axon Capital LLC $387

Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.